Danaher expects mid-single digit revenue growth in fourth quarter

Danaher Corporation (NYSE: DHR) announced that CEO Rainer M. Blair will present the company's fourth quarter 2025 performance at the J.P. Morgan Healthcare Conference on January 13, 2026 at 11:15 a.m. PT.

The life sciences and diagnostics company provided preliminary financial estimates for the fourth quarter and full year 2025. Fourth quarter revenues are anticipated to increase in the mid-single digit percent range compared to the same period in 2024. Non-GAAP core revenue growth for the quarter is expected to be toward the high-end of the company's previously announced low-single digit percentage guidance.

For the full year 2025, Danaher expects non-GAAP adjusted diluted net earnings per share to be toward the high-end of its previously announced guidance range of $7.70 to $7.80.

"Our team executed well to deliver a solid finish to 2025. We were especially pleased with continued strength in Bioprocessing and better-than-expected Life Sciences and Diagnostics revenue in the fourth quarter," Blair stated in the announcement.

The presentation will be webcast on Danaher's website under the "Investors" section. The company will hold its quarterly earnings conference call for the fourth quarter and full year 2025 on January 28, 2026 at 8:00 a.m. ET.

Danaher operates as a global life sciences and diagnostics company with approximately 63,000 employees worldwide. The information is based on a company press release statement.

You May Also Be Interested In

• Morgan Stanley Starts Amplifon SpA (AMP:IM) (AMFPF) at Overweight
• Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance